Modeled PFOA Exposure and Coronary Artery Disease, Hypertension, and High Cholesterol in Community and Worker Cohorts

被引:135
作者
Winquist, Andrea [1 ]
Steenland, Kyle [1 ]
机构
[1] Emory Univ, Dept Environm Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
关键词
AMMONIUM PERFLUOROOCTANOATE PRODUCTION; SERUM-LIPIDS; LIVER-ENZYMES; ACID; ASSOCIATION; POPULATION; PARAMETERS; MORTALITY; PLANT;
D O I
10.1289/ehp.1307943
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Background: Several previous studies, mostly cross-sectional, have found associations between perfluorooctanoic acid (PFOA) and high cholesterol levels, but studies of hypertension and heart disease have had inconsistent findings. Objectives: In this study we examined the association between modeled PFOA exposure and incident hypertension, hypercholesterolemia, and coronary artery disease among workers at a Mid-Ohio Valley chemical plant that used PFOA, and residents of the surrounding community. Methods: Community-and worker-cohort participants completed surveys during 2008-2011 covering demographics, health-related behaviors, and medical history. Cox proportional hazard models, stratified by birth year, modeled the hazard of each outcome (starting at 20 years of age) as a function of retrospective serum PFOA concentration estimates (generated through fate, transport and exposure modeling), controlling for sex, race, education, smoking, alcohol use, body mass index, and diabetes. Results: Among 32,254 participants (28,541 community; 3,713 worker), 12,325 reported hypertension with medication, 9,909 reported hypercholesterolemia with medication, and 3,147 reported coronary artery disease (2,550 validated). Hypercholesterolemia incidence increased with increasing cumulative PFOA exposure (sum of yearly serum concentration estimates), most notably among males 40-60 years of age. Compared with the lowest exposure quintile (< 142 ng/mL-years), hazard ratios for subsequent quintiles (ng/mL-years: 142 to < 234; 234 to < 630; 630 to < 3,579; = 3,579) were 1.24, 1.17, 1.19, and 1.19 overall and 1.38, 1.32, 1.31, and 1.44 among men 40-60 years of age. There was no apparent association between PFOA exposure and hypertension or coronary artery disease incidence. Conclusions: Higher PFOA exposure was associated with incident hypercholesterolemia with medication, but not with hypertension or coronary artery disease.
引用
收藏
页码:1299 / 1305
页数:7
相关论文
共 39 条
[1]   Left Truncation, Susceptibility, and Bias in Occupational Cohort Studies [J].
Applebaum, Katie M. ;
Malloy, Elizabeth J. ;
Eisen, Ellen A. .
EPIDEMIOLOGY, 2011, 22 (04) :599-606
[2]   Rate of Decline in Serum PFOA Concentrations after Granular Activated Carbon Filtration at Two Public Water Systems in Ohio and West Virginia [J].
Bartell, Scott M. ;
Calafat, Antonia M. ;
Lyu, Christopher ;
Kato, Kayoko ;
Ryan, P. Barry ;
Steenland, Kyle .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2010, 118 (02) :222-228
[3]   Thirty Years of Medical Surveillance in Perfluooctanoic Acid Production Workers [J].
Costa, Giovanni ;
Sartori, Samantha ;
Consonni, Dario .
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2009, 51 (03) :364-372
[4]   Community exposure to perfluorooctanoate: Relationships between serum levels and certain health parameters [J].
Emmett, Edward Anthony ;
Zhang, Hong ;
Shofer, Frances Susan ;
Freeman, David ;
Rodway, Nancy Virginia ;
Desai, Chintan ;
Shaw, Leslie Michael .
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2006, 48 (08) :771-779
[5]   Association between Plasma PFOA and PFOS Levels and Total Cholesterol in a Middle-Aged Danish Population [J].
Eriksen, Kirsten T. ;
Raaschou-Nielsen, Ole ;
McLaughlin, Joseph K. ;
Lipworth, Loren ;
Tjonneland, Anne ;
Overvad, Kim ;
Sorensen, Mette .
PLOS ONE, 2013, 8 (02)
[6]   Do perfluoroalkyl substances affect metabolic function and plasma lipids?-Analysis of the 2007-2009, Canadian Health Measures Survey (CHMS) Cycle 1 [J].
Fisher, Mandy ;
Arbuckle, Tye E. ;
Wade, Mike ;
Haines, Douglas A. .
ENVIRONMENTAL RESEARCH, 2013, 121 :95-103
[7]   Reductions in Serum Lipids with a 4-year Decline in Serum Perfluorooctanoic Acid and Perfluorooctanesulfonic Acid [J].
Fitz-Simon, Nicola ;
Fletcher, Tony ;
Luster, Michael I. ;
Steenland, Kyle ;
Calafat, Antonia M. ;
Kato, Kayoko ;
Armstrong, Ben .
EPIDEMIOLOGY, 2013, 24 (04) :569-576
[8]  
Frisbee SJ, 2010, ARCH PEDIAT ADOL MED, V164, P860, DOI 10.1001/archpediatrics.2010.163
[9]   The C8 Health Project: Design, Methods, and Participants [J].
Frisbee, Stephanie J. ;
Brooks, A. Paul, Jr. ;
Maher, Arthur ;
Flensborg, Patsy ;
Arnold, Susan ;
Fletcher, Tony ;
Steenland, Kyle ;
Shankar, Anoop ;
Knox, Sarah S. ;
Pollard, Cecil ;
Halverson, Joel A. ;
Vieira, Veronica M. ;
Jin, Chuanfang ;
Leyden, Kevin M. ;
Ducatman, Alan M. .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2009, 117 (12) :1873-1882
[10]   Perfluorinated compounds - Exposure assessment for the general population in western countries [J].
Fromme, Hermann ;
Tittlemier, Sheryl A. ;
Voelkel, Wolfgang ;
Wilhelm, Michael ;
Twardella, Dorothee .
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH, 2009, 212 (03) :239-270